Department of Experimental and Clinical Pharmacology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.
Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modelling Lab, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland.
Biomolecules. 2020 May 20;10(5):793. doi: 10.3390/biom10050793.
Metabotropic glutamate subtype 5 (mGlu5) receptors are implicated in various forms of synaptic plasticity, including drugs of abuse. In drug-addicted individuals, associative memories can drive relapse to drug use. The present study investigated the potential of the mGlu5 receptor positive allosteric modulator (PAM), VU-29 (30 mg/kg, i.p.), to inhibit the maintenance of a learned association between ethanol and environmental context by using conditioned place preference (CPP) in rats. The ethanol-CPP was established by the administration of ethanol (1.0 g/kg, i.p. × 10 days) using an unbiased procedure. Following ethanol conditioning, VU-29 was administered at various post-conditioning times (ethanol free state at the home cage) to ascertain if there was a temporal window during which VU-29 would be effective. Our experiments indicated that VU-29 did not affect the expression of ethanol-induced CPP when it was given over two post-conditioning days. However, the expression of ethanol-CPP was inhibited by 10-day home cage administration of VU-29, but not by first 2-day or last 2-day injection of VU-29 during the 10-day period. These findings reveal that VU-29 can inhibit the maintenance of ethanol-induced CPP, and that treatment duration contributes to this effect of VU-29. Furthermore, VU-29 effect was reversed by pretreatment with either MTEP (the mGlu5 receptor antagonist), or MK-801 (the N-methyl-D-aspartate-NMDA receptor antagonist). Thus, the inhibitory effect of VU-29 is dependent on the functional interaction between mGlu5 and NMDA receptors. Because a reduction in ethanol-associated cues can reduce relapse, mGlu5 receptor PAM would be useful for therapy of alcoholism. Future research is required to confirm the current findings.
代谢型谷氨酸受体 5(mGlu5)受体参与各种形式的突触可塑性,包括药物滥用。在吸毒成瘾者中,联想记忆可以促使他们重新使用药物。本研究通过在大鼠中使用条件位置偏好(CPP)来研究 mGlu5 受体正变构调节剂(PAM)VU-29(30mg/kg,ip)抑制乙醇与环境背景之间习得性关联的维持的潜力。通过使用无偏置程序给予乙醇(1.0g/kg,ip×10 天)来建立乙醇-CPP。在乙醇调节后,在各种条件后时间(在自家笼中无乙醇状态)给予 VU-29,以确定 VU-29 是否在有效时间窗口内。我们的实验表明,当 VU-29 在两个条件后日给予时,它不会影响乙醇诱导的 CPP 的表达。然而,10 天的自家笼内给予 VU-29 抑制了乙醇-CPP 的表达,但在 10 天期间,第一次 2 天或最后 2 天注射 VU-29 则没有。这些发现表明,VU-29 可以抑制乙醇诱导的 CPP 的维持,并且治疗持续时间有助于 VU-29 的这种作用。此外,VU-29 的作用可以通过预先给予 MTEP(mGlu5 受体拮抗剂)或 MK-801(N-甲基-D-天冬氨酸-NMDA 受体拮抗剂)来逆转。因此,VU-29 的抑制作用取决于 mGlu5 和 NMDA 受体之间的功能相互作用。因为减少与乙醇相关的线索可以减少复发,因此 mGlu5 受体 PAM 将有助于治疗酒精中毒。需要进一步的研究来证实当前的发现。